Xcout Intel
Hepta
Hepta Bio, Inc. focuses on developing liquid biopsy technology for metabolic dysfunction-associated conditions, with headquarters in California.
Subscribe to see Hepta’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Hepta at a glance
Hepta is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $6.7M in November 2025. Xcout tracks 2 named people at Hepta, including Hamed Amini (Chief Executive Officer & Co-Founder).
Hepta leadership
- Hamed AminiChief Executive Officer & Co-Founder
- Soheil DamangirChief Technology Officer & Co-Founder
Hepta funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6.7M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Hepta competitors
A few of Hepta's closest competitors — see the full list of competitors and alternatives →
QuantumCyte, Inc. operates in the biotechnology research industry, focusing on specialized cellular and tissue analysis solutions. Founded in 2013, the company is headquartered in Fremont, California.
BioROSA Technologies is a biotechnology company that develops a blood-based metabolomics and machine learning platform for the early diagnosis and assessment of Autism Spectrum Disorder. Founded in 2018, the company focuses on creating biologically-based screening and diagnostic standards to detect ASD in young children.
Liquid BioScience, Inc. is a biotechnology company operating within the United States, focusing on advanced analytics and diagnostics in the biotech sector.
Adaptyx Biosciences is an early-stage biotechnology company located in Menlo Park, California, developing wearable sensors and biochemical assays for continuous health and biomarker intelligence.
Elypta AB is a private biotech company headquartered in Solna, Sweden, operating on the Karolinska Institute campus. The firm focuses on developing cancer detection tests based on metabolism and liquid biopsy biomarkers.
Newomics Inc. is a privately-held biotechnology company headquartered in California that develops and commercializes advanced mass spectrometry solutions. The company provides innovative front-end systems and analytical tools for life sciences and research markets.
Get Hepta's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Hepta in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access